New developments in the treatment of chemotherapy-induced neutropenia: focus on balugrastim

Overview of attention for article published in Therapeutics and Clinical Risk Management, June 2016

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (84th percentile)
High Attention Score compared to outputs of the same age and source (94th percentile)

Mentioned by

news: 1 news outlet

twitter: 4 X users

Readers on

mendeley: 9 Mendeley

So far, Altmetric has seen 1 news story.

Safety, Efficacy of Balugrastim to Treat Chemotherapy-Induced Neutropenia

AJMC, 12 Jul 2016

Researchers assessed balugrastim’s efficacy, safety, and tolerability in 4 different clinical trials and found it to be a…